Investor

FT Global Pharmaceutical and Biotechnology Summit

Name: FT Global Pharmaceutical and Biotechnology Summit
Location: London, UK

A high level executive summit addressing global biopharma trends, drug discovery innovation, and clinical trial technology.

When: November, Early November
Where: London, UKView on Google Maps
Format: Hybrid
Organiser: Financial Times
Region: Europe
Scale: About 500 attendees
Founded: 2000

The Signal

The FT Global Pharmaceutical and Biotechnology Summit is a premium conference focusing on the business of medicine. Organized by the Financial Times, it brings together life science CEOs, institutional investors, and healthcare policymakers. Sessions explore the commercial challenges of drug development, market access, and the adoption of AI in therapeutics. For healthtech investors and operators, it offers crucial macro-level perspectives on biopharma budgets and technology buying habits.

What to expect

AI driven drug discovery investments
Clinical trial digitization strategies
Global pharmaceutical pricing policies
Gene therapy manufacturing scalability

Who is in the room

Pharmaceutical executives, biotechnology founders, life science venture capitalists, investment bankers, and regulators attend.

Background

Originally focused on traditional pharmaceutical business dynamics, the FT Summit has increasingly prioritized biotechnology breakthroughs and digital health partnerships. It remains one of Europe's most prestigious gatherings for life science leadership.

Official event site